glp-1 weight loss plateau causes Plateau: & Solutions Weight Reduction with GLP-1 Agonists

Excess body fat contributes to various conditions, including heart disease, diabetes, stroke, certain types of cancer, and other adverse health outcomes

This was a dedicated CV outcome trial, enrolling high-risk overweight and obese patients (without DM type 2) and showed an early reduction in all-cause mortality and a 20 per cent RR reduction in hard end clinical endpoints

The short answer, according to this genetic analysis of more than 800,000 individuals, is yesbut significantly less than fat loss

One area gaining attention is the use of GLP-1 (glucagon-like peptide-1) receptor agonists

Always consult with your provider to ensure treatments are coordinated effectively and safely